<DOC>
	<DOCNO>NCT02000128</DOCNO>
	<brief_summary>1 . Purpose : investigate effect bioimpedance analysis ( BIA ) guide fluid management versus experiential way clinical outcome peritoneal dialysis patient . 2 . Design : prospective , randomize , control , single center study 3 . Study hypothesis : Patients peritoneal dialysis frequently hypervolemic , associated increase hazard death cardiovascular event . Bioimpedance analysis safe , easy way , appear useful sensitive technique assess volume status dialysis patient . Therefore hypothesize concise strict fluid management guide BIA may help improve patient ' survival , decrease cardiovascular event hospitalization rate . 4 . Objects : incident prevalent patient overhydration status . 1. anticipated cases:240 2. arm : patient randomize two arm . ( BIA group/clinical group ) 3. observational time:12 month 5 . Primary Outcome : cause mortality . Secondary Outcomes : technique survival , cardiovascular event , peritonitis , residual renal function .</brief_summary>
	<brief_title>Fluid Management Guided Bioimpedance Analysis Peritoneal Dialysis ( PD ) Patients .</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>patient undergo peritoneal dialysis clinically stable least 3 month ; 18 Years old ; ratio extracellular water ( ECW ) /total body water ( TBW ) â‰§0.4 ; sign informed consent patient mental graft ; amputation ; patient unable accomplish BIA measurement stand position 3 minute ; patient whose heart function class IV estimate New York Heart Association ( NYHA ) standard ; Patients acute complication within 30 day prior study enrollment ; patient whose life expectancy within 6 month ; patient pregnant ; patient unable give consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Peritoneal Dialysis</keyword>
	<keyword>fluid overload</keyword>
	<keyword>bioimpedance analysis</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>